{"name":"Aravis Ventures","permalink":"aravis-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/aravis-ventures","homepage_url":"http://www.aravis.ch/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+41 43 499 2000","description":"venture company","email_address":"info@aravis.ch","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"Venture Associates AG","created_at":"Mon Apr 13 21:07:03 UTC 2009","updated_at":"Mon Oct 26 10:45:11 UTC 2009","overview":"<p>Aravis Ventures is a financial organisation which targets its investments in the fields of life sciences and renewable energy. Their investments are focused in Europe, Asia and North America.</p>","image":{"available_sizes":[[[150,38],"assets/images/resized/0004/8028/48028v1-max-150x150.jpg"],[[209,54],"assets/images/resized/0004/8028/48028v1-max-250x250.jpg"],[[209,54],"assets/images/resized/0004/8028/48028v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"Lehfrauenweg 10","address2":"","zip_code":"CH-8053","city":"Zuerich","state_code":null,"country_code":"CHE","latitude":47.3596741,"longitude":8.5899823}],"relationships":[{"is_past":false,"title":"CFA","person":{"first_name":"Jean-Philippe","last_name":"Tripet","permalink":"jean-philippe-tripet","image":{"available_sizes":[[[103,122],"assets/images/resized/0004/8029/48029v1-max-150x150.jpg"],[[103,122],"assets/images/resized/0004/8029/48029v1-max-250x250.jpg"],[[103,122],"assets/images/resized/0004/8029/48029v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Managing Partner","person":{"first_name":"Simon","last_name":"Nebel","permalink":"simon-nebel","image":null}},{"is_past":false,"title":"CFA","person":{"first_name":"Dr.","last_name":"Oliver Thalmann","permalink":"dr-oliver-thalmann","image":{"available_sizes":[[[104,122],"assets/images/resized/0004/8030/48030v1-max-150x150.jpg"],[[104,122],"assets/images/resized/0004/8030/48030v1-max-250x250.jpg"],[[104,122],"assets/images/resized/0004/8030/48030v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/synosia-raises-29m-phase-ii-testing/2009-01-07","source_description":"Synosia raises $29M for Phase II testing","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":null,"company":{"name":"Synosia Therapeutics","permalink":"synosia-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/3264/43264v1-max-150x150.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-250x250.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/ambrx-inc-series-d-10m/","source_description":"Ambrx, Inc.: Series D $10M","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":4,"funded_day":1,"company":{"name":"Ambrx","permalink":"ambrx","image":{"available_sizes":[[[150,53],"assets/images/resized/0004/1068/41068v1-max-150x150.png"],[[194,69],"assets/images/resized/0004/1068/41068v1-max-250x250.png"],[[194,69],"assets/images/resized/0004/1068/41068v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/novimmune-sa-series-c-548m/","source_description":"NovImmune, SA: Series C $54.8M","raised_amount":54800000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":12,"company":{"name":"NovImmune","permalink":"novimmune","image":{"available_sizes":[[[150,44],"assets/images/resized/0004/9228/49228v1-max-150x150.png"],[[250,74],"assets/images/resized/0004/9228/49228v1-max-250x250.png"],[[262,78],"assets/images/resized/0004/9228/49228v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Capital Report Index","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":10,"funded_day":20,"company":{"name":"S*Bio","permalink":"s-bio","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/8400/48400v1-max-150x150.png"],[[195,80],"assets/images/resized/0004/8400/48400v1-max-250x250.png"],[[195,80],"assets/images/resized/0004/8400/48400v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/evolva-sa-series-b-275m/","source_description":"Evolva, SA: Series B $27.5M","raised_amount":27500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":7,"company":{"name":"Evolva","permalink":"evolva","image":{"available_sizes":[[[74,93],"assets/images/resized/0006/4029/64029v1-max-150x150.jpg"],[[74,93],"assets/images/resized/0006/4029/64029v1-max-250x250.jpg"],[[74,93],"assets/images/resized/0006/4029/64029v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://investor.omeros.com/releasedetail.cfm?ReleaseID=410872","source_description":"Omeros Raises More Than $63 Million in Financing","raised_amount":63000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":2,"funded_day":12,"company":{"name":"Omeros","permalink":"omeros","image":{"available_sizes":[[[150,101],"assets/images/resized/0008/4223/84223v1-max-150x150.jpg"],[[192,130],"assets/images/resized/0008/4223/84223v1-max-250x250.jpg"],[[192,130],"assets/images/resized/0008/4223/84223v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.bioportfolio.com/news/Borean_Pharma_2.htm","source_description":"Borean Pharma raises Euros 4 Million in series A fundraising","raised_amount":4000000,"raised_currency_code":"EUR","funded_year":2005,"funded_month":3,"funded_day":23,"company":{"name":"Borean Pharma","permalink":"borean-pharma","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/merlion-pharmaceuticals-pte-ltd-series-c-7m/","source_description":"MerLion Pharmaceuticals Pte. Ltd.: Series C $7M","raised_amount":7000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":11,"company":{"name":"MerLion Pharmaceuticals","permalink":"merlion-pharmaceuticals","image":{"available_sizes":[[[150,64],"assets/images/resized/0010/5172/105172v1-max-150x150.png"],[[185,79],"assets/images/resized/0010/5172/105172v1-max-250x250.png"],[[185,79],"assets/images/resized/0010/5172/105172v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.synosia.com/list-details.aspx?listguid=E8469572-06DC-475F-9815-2A91E1232F9A&folderguid=801EEB72-27A8-495F-8A19-242E20F5F875","source_description":"Synosia Therapeutics Raises $30M in Series C Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":12,"company":{"name":"Synosia Therapeutics","permalink":"synosia-therapeutics","image":{"available_sizes":[[[150,49],"assets/images/resized/0004/3264/43264v1-max-150x150.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-250x250.png"],[[217,71],"assets/images/resized/0004/3264/43264v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/telormedix-sa-series-b-83m/","source_description":"Telormedix, SA.: Series B $8.3M","raised_amount":8300000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":28,"company":{"name":"Telormedix","permalink":"telormedix","image":{"available_sizes":[[[150,58],"assets/images/resized/0016/9590/169590v1-max-150x150.jpg"],[[206,80],"assets/images/resized/0016/9590/169590v1-max-250x250.jpg"],[[206,80],"assets/images/resized/0016/9590/169590v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}